OpenBench and Tavros Therapeutics Announce Collaboration to

OpenBench and Tavros Therapeutics Announce Collaboration to Pursue First-in-class Cancer Target

/PRNewswire/ -- Tavros Therapeutics, a privately held biotechnology company discovering first-in-class cancer therapies, and OpenBench, an emerging leader in...

Related Keywords

North Carolina , United States , James Yoder , Eoin Mcdonnell , Jim Thompson , Openbench Inc , , Hemoshear Therapeutics , Openbench Tavros Therapeutics ,